BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31042320)

  • 1. Imaging at diagnosis impacts cancer-specific survival among patients with cancer of the oropharynx.
    Morgan RL; Eguchi MM; Mueller AC; Daugherty SL; Amini A; Karam SD
    Cancer; 2019 Aug; 125(16):2794-2802. PubMed ID: 31042320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of Imaging after Lung Cancer Resection. 1992-2005.
    Sharma G; Nishi SP; Lin YL; Kuo YF; Goodwin JS; Riall TS
    Ann Am Thorac Soc; 2016 Sep; 13(9):1559-67. PubMed ID: 27243464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
    Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
    JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
    Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
    Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
    Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination.
    Thiagarajan A; Caria N; Schöder H; Iyer NG; Wolden S; Wong RJ; Sherman E; Fury MG; Lee N
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):220-7. PubMed ID: 22035663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Value of Fused PET/MRI for Surgical Planning in Patients With Oral/Oropharyngeal Carcinoma.
    Hayashi K; Kikuchi M; Imai Y; Yamashita D; Hino M; Ito K; Shimizu K; Harada H; Shinohara S
    Laryngoscope; 2020 Feb; 130(2):367-374. PubMed ID: 30897225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET, combined FDG-PET/CT and MRI for evaluation of bone marrow infiltration in staging of lymphoma: a systematic review and meta-analysis.
    Wu LM; Chen FY; Jiang XX; Gu HY; Yin Y; Xu JR
    Eur J Radiol; 2012 Feb; 81(2):303-11. PubMed ID: 21145680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
    Tsujikawa T; Narita N; Kanno M; Takabayashi T; Fujieda S; Okazawa H
    Ann Nucl Med; 2018 May; 32(4):239-249. PubMed ID: 29488161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx.
    Kim MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Surg Oncol; 2007 Jun; 33(5):633-8. PubMed ID: 17391904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer.
    Qu X; Huang X; Yan W; Wu L; Dai K
    Eur J Radiol; 2012 May; 81(5):1007-15. PubMed ID: 21354739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of County-Level Socioeconomic Status on Oropharyngeal Cancer Survival in the United States.
    Megwalu UC
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):665-670. PubMed ID: 28195022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oropharyngeal cancer: current understanding and management.
    Cohan DM; Popat S; Kaplan SE; Rigual N; Loree T; Hicks WL
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):88-94. PubMed ID: 19373958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
    Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
    Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.
    Antoch G; Vogt FM; Freudenberg LS; Nazaradeh F; Goehde SC; Barkhausen J; Dahmen G; Bockisch A; Debatin JF; Ruehm SG
    JAMA; 2003 Dec; 290(24):3199-206. PubMed ID: 14693872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.